Literature DB >> 25955817

NPR-A: A Therapeutic Target in Inflammation and Cancer.

Jia Zhang1, Min Li1, Ya Yang1, Yan Yan2, Junhai Li3, Jingkun Qu2, Jiansheng Wang1.   

Abstract

Natriuretic peptide receptor A (NPR-A) is the receptor for atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP). NPR-A plays critical physiological and pathophysiological roles in several target cell and tissue system processes, such as cell growth, apoptosis, proliferation, and inflammation. Accumulating data demonstrate that NPR-A is involved in immune and inflammatory reactions and is a potential target in inflammation treatment. It is expressed in various cancer cells and is important for tumor growth. A recent study indicated that NPR-A signaling can regulate stem cell recruitment and angiogenesis. This signaling can serve as a model for studying the linkage between inflammation and tumorigenesis. In this review we highlight the mechanisms by which NPR-A affects signaling pathways involved in inflammation and cancer, and we discuss its potential as a novel target in inflammation, cancer, and cancer-related inflammation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25955817     DOI: 10.1615/critreveukaryotgeneexpr.2015012447

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  8 in total

Review 1.  The multifaceted role of natriuretic peptides in metabolic syndrome.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Mulugeta Seneshaw; Faridoddin Mirshahi; Arun J Sanyal
Journal:  Biomed Pharmacother       Date:  2017-06-07       Impact factor: 6.529

2.  cGMP signaling pathway that modulates NF-κB activation in innate immune responses.

Authors:  Hirotaka Kanoh; Shinzo Iwashita; Takayuki Kuraishi; Akira Goto; Naoyuki Fuse; Haruna Ueno; Mariko Nimura; Tomohito Oyama; Chang Tang; Ryo Watanabe; Aki Hori; Yoshiki Momiuchi; Hiroki Ishikawa; Hiroaki Suzuki; Kumiko Nabe; Takeshi Takagaki; Masataka Fukuzaki; Li-Li Tong; Sinya Yamada; Yoshiteru Oshima; Toshiro Aigaki; Julian A T Dow; Shireen-Anne Davies; Shoichiro Kurata
Journal:  iScience       Date:  2021-11-18

3.  Differential effects of low-dose sacubitril and/or valsartan on renal disease in salt-sensitive hypertension.

Authors:  Iuliia Polina; Mark Domondon; Rebecca Fox; Anastasia V Sudarikova; Miguel Troncoso; Valeriia Y Vasileva; Yuliia Kashyrina; Monika Beck Gooz; Ryan S Schibalski; Kristine Y DeLeon-Pennell; Wayne R Fitzgibbon; Daria V Ilatovskaya
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-28

4.  Effects of elevation of ANP and its deficiency on cardiorenal function.

Authors:  Daria V Ilatovskaya; Vladislav Levchenko; Kristen Winsor; Gregory R Blass; Denisha R Spires; Elizaveta Sarsenova; Iuliia Polina; Adrian Zietara; Mark Paterson; Alison J Kriegel; Alexander Staruschenko
Journal:  JCI Insight       Date:  2022-05-09

5.  Natriuretic Peptides Regulate Prostate Cells Inflammatory Behavior: Potential Novel Anticancer Agents for Prostate Cancer.

Authors:  Letizia Mezzasoma; Vincenzo Nicola Talesa; Egidia Costanzi; Ilaria Bellezza
Journal:  Biomolecules       Date:  2021-05-25

Review 6.  Natriuretic Peptides: The Case of Prostate Cancer.

Authors:  Letizia Mezzasoma; Matthew J Peirce; Alba Minelli; Ilaria Bellezza
Journal:  Molecules       Date:  2017-10-10       Impact factor: 4.411

7.  N-terminal-pro-B-type-natriuretic peptide associated with 2-year mortality from both cardiovascular and non-cardiovascular origins in prevalent chronic hemodialysis patients.

Authors:  Chihiro Kawagoe; Yuji Sato; Tatsunori Toida; Hideto Nakagawa; Yasuhiro Yamashita; Akihiro Fukuda; Shuji Iwatsubo; Shouichi Fujimoto
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

Review 8.  Modified natriuretic peptides and their potential roles in cancer treatment.

Authors:  Mengjiao Xu; Xingzhu Liu; Ping Li; Yadong Yang; Wenyuan Zhang; Siyu Zhao; Ying Zeng; Xile Zhou; Ling-Hui Zeng; Geng Yang
Journal:  Biomed J       Date:  2021-07-06       Impact factor: 7.892

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.